-+ 0.00%
-+ 0.00%
-+ 0.00%

Filana Therapeutics Q2 EPS $(0.18) Beats $(0.23) Estimate

Benzinga·07/29/2026 12:04:28
Listen to the news
Filana Therapeutics (NASDAQ:FLNA) reported quarterly losses of $(0.18) per share which beat the analyst consensus estimate of $(0.23) by 18.18 percent. This is a 80.43 percent increase over losses of $(0.92) per share from the same period last year.